In Lab Tests, Researchers Halt Arrhythmias With Gentle Beams—Not Harsh Electric Shocks
Using high-tech human heart models and mouse experiments, scientists at Johns Hopkins and Germany’s University of Bonn have shown that beams of light could replace electric shocks in patients reeling from a deadly heart rhythm disorder.
The findings, published online Sept. 12 in the October 2016 edition of The Journal of Clinical Investigation, could pave the way for a new type of implantable defibrillators.
Current devices deliver pulses of electricity that are extremely painful and can damage heart tissue. Light-based treatment, the Johns Hopkins and Bonn researchers say, should provide a safer and gentler remedy for patients at high risk of arrhythmia, an irregular heartbeat that can cause sudden cardiac death within minutes.
This idea springs from advances in the field of optogenetics, in which light-sensitive proteins are embedded in living tissue, enabling the use of light sources to modify electrical activity in cells.
“We are working towards optical defibrillation of the heart, where light will be given to a patient who is experiencing cardiac arrest, and we will be able to restore the normal functioning of the heart in a gentle and painless manner,” said Natalia Trayanova, who supervised the research at Johns Hopkins.
Trayanova is the Murray B. Sachs Professor in the Department of Biomedical Engineering and is a core faculty member in the university’sInstitute for Computational Medicine.
To move the new heart treatment closer to reality, the scientists at the University of Bonn and Johns Hopkins focused on two different types of research.
The Bonn team conducted tests on beating mouse hearts whose cells had been genetically engineered to express proteins that react to light and alter electrical activity within the organ.
When the Bonn researchers triggered ventricular fibrillation in the mouse heart, a light pulse of one second applied to the heart was enough to restore normal rhythm. “This is a very important result,” said Tobias Bruegmann, one of the lead authors of the journal article. “It shows for the first time experimentally that light can be used for defibrillation of cardiac arrhythmia.”
To find out if this technique could help human patients, Trayanova’s team at Johns Hopkins performed an analogous experiment within a detailed computer model of a human heart, one derived from MRI scans taken of a patient who had experienced a heart attack and was now at risk of arrhythmia.
“Our simulations show that a light pulse to the heart could stop the cardiac arrhythmia in this patient,” said Patrick M. Boyle, a Johns Hopkins biomedical engineering research professor who was also a lead author of the journal article.
To do so, however, the method from the University of Bonn had to be tweaked for the human heart by using red light to stimulate the heart cells, instead of the blue light used in mice. Boyle, who is a member of Trayanova’s lab team, explained that the blue light used in the much smaller mouse hearts was not powerful enough to fully penetrate human heart tissue. The red light, which has a longer wavelength, was more effective in the virtual human tests.
“In addition to demonstrating the feasibility of optogenetic defibrillation in a virtual heart of a patient, the simulations revealed the precise ways in which light alters the collective electrical behavior of the cells in the heart to achieve the desired arrhythmia termination,” Trayanova said.
Boyle added that this aspect of the study highlighted the important role that computational modeling can play in guiding and accelerating the development of therapeutic applications for cardiac optogenetics, a technology that is still in its infancy.
Junior Professor Philipp Sasse of the Institute of Physiology I at the University of Bonn, who is corresponding author of the study and supervised the project in Germany, agreed that the promising light treatment will require much more time and research before it can become a commonplace medical procedure.
“The new method is still in the stage of basic research,” Sasse said. “Until implantable optical defibrillators can be developed for the treatment of patients, it will still take at least five to ten years.”
Learn more: Light Tames Lethal Heart Disorders in Mice and Virtual Humans
The Latest on: Optogenetic defibrillation
[google_news title=”” keyword=”optogenetic defibrillation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Optogenetic defibrillation
- Antitachycardia Pacing for Ventricular Tachycardia Using Implantable Cardioverter Defibrillatorson May 17, 2024 at 5:00 pm
Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...
- Life-saving defibrillators installed at every Fire Station in Northern Irelandon May 9, 2024 at 9:18 pm
The Northern Ireland Fire & Rescue Service (NIFRS) has installed life-saving Defibrillators (AEDs) at all of its 67 fire stations across the region, as well as at its headquarters in Lisburn.
- Defibtech Defibrillator and Accessorieson April 26, 2024 at 5:00 pm
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
- Gentle defibrillation for the heart: A milder method developed by researchers for cardiac arrhythmiason April 23, 2024 at 12:36 pm
This may result in advanced defibrillators causing less pain and side-effects for patients. More information: S. Hussaini et al, Efficient termination of cardiac arrhythmias using optogenetic ...
- Gentle defibrillation for the hearton April 22, 2024 at 4:59 pm
Efficient termination of cardiac arrhythmias using optogenetic resonant feedback pacing. Chaos: An Interdisciplinary Journal of Nonlinear Science , 2024; 34 (3) DOI: 10.1063/5.0191519 Cite This Page : ...
- Gentle defibrillation for the hearton April 22, 2024 at 4:59 pm
A cardiac ventricular arrhythmia can be converted to a normal sinus rhythm (white line) by using a sequence of light pulses (blue line) in an optogenetic mouse heart. Applying such pulsed light ...
- Avive pockets $57M for portable defibrillator to speed up cardiac arrest responseon April 21, 2024 at 7:30 pm
Portable defibrillator company Avive Solutions raised $56.5 million in growth equity financing to build out its staff and commercial developments. The company has established a network of ...
- Philips HeartStart OnSite Defibrillatoron April 20, 2024 at 5:00 pm
The Philips HeartStart OnSite Defibrillator is designed to be the easiest-to-use, and most reliable defibrillator available. Available without a prescription from ActiveForever.com, the Philips ...
- Campaigner secures defibrillator in friend's memoryon April 5, 2024 at 11:48 pm
Student paramedic Amy Shadbolt and Professor Sally Moyle, pro vice-chancellor for health and science at the University of Worcester where there are six defibrillators A paramedic student at the ...
via Bing News